John Wilkin
Stock Analyst at Craig-Hallum
(1.15)
# 3,664
Out of 4,915 analysts
5
Total ratings
40%
Success rate
-1.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $8.63 | +39.05% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $10.44 | +43.68% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $23.97 | +87.73% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $5.59 | +43.11% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $4.05 | +616.05% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $8.63
Upside: +39.05%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $10.44
Upside: +43.68%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $23.97
Upside: +87.73%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $5.59
Upside: +43.11%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $4.05
Upside: +616.05%